// App-Quantinova.ai

393 : Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis.

Researchers

Presenter

  • Antonio D'Alessio

Principal Investigators

  • Arndt Weinmann

  • Peter R. Galle

  • Claudia Angela Maria Fulgenzi

  • Dominik Bettinger

  • Bertram Bengsch

  • Arndt Vogel

  • Lorenz Balcar

  • Bernhard Scheiner

  • Musharraf Navaid

  • Abdul Rafeh Naqash

  • Nicola Personeni

  • Tiziana Pressiani

  • Rohini Sharma

  • Matthias Pinter

  • Alessio Cortellini

  • Lorenza Rimassa

  • David James Pinato

Medical Centers

  • Imperial College, London, United Kingdom

  • University Medical Center Mainz, Mainz, Germany

  • Department of Orthopaedic Surgery, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

  • Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy

  • Department of Medicine II: Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Medical Center - University of Freiburg, Freiburg, Germany

  • Hannover Medical School, Hannover, Germany

  • Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

  • Department of Hematology/Oncology, East Carolina University, Greenville, NC

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy

  • IRCCS Humanitas Research Center, Rozzano, Italy

  • Department of Biotechnological and Applied Clinical Sciences, University of LAquila, LAquila, Italy

  • Humanitas University, Pieve Emanuele, Italy

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Germany

  • Italy

  • Austria

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

  • Cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • Atezolizumab

  • Bevacizumab

Outcome

  • N/A


Study Design

  • Observational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A